These vectors carried the Cre recombinase gene controlled by a glial fibrillary acidic protein (GFAP) promoter, along with sgRNA under the control of a U6 promoter, targeting 56 genes commonly mutated in human cancers (50) (Table 1 and Figures 3A–D). The gene discussed is GFAP; the disease is cancer.